Northwest Pipe (NASDAQ:NWPX) Reports Bullish Q2 CY2026

Northwest Pipe (NASDAQ:NWPX) reported Q2 CY2026 results. Revenue rose 19.7% year on year to $159.5 million, exceeding Wall Street estimates by 3.1%, and GAAP diluted EPS was $1.62, 22% above consensus. The company cited record results and said analysts expect revenue growth of 3.1% over the next 12 months.

Original reporting
Published Jul 29, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Northwest Pipe (NASDAQ:NWPX) Reports Bullish Q2 CY2026 — source image
Decision brief

The 30-second read

$NWPXBullishMed
01

Why it matters

Q2 results beat revenue and EPS expectations, with operating margin rising to 13.3% (+3.3 pp YoY). However, the next-12-month outlook implies slower revenue growth and a small full-year EPS decline.

02

Market read

This is a company-specific earnings beat with margin expansion, but forward EPS is expected to slightly contract, shaping the risk-reward for new positions.

03

What to watch

The piece does not break out backlog, contract timing, or cash flow quality; traders may need to verify whether margin expansion is sustainable or one-off.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session reaction to Q2 CY2026 results (stock noted flat at $123.44 immediately after reporting)

Background

Northwest Pipe is a water infrastructure pipeline systems manufacturer, including work tied to Texas integrated pipeline (IPL) delivering about 350 million gallons per day.

Company-level read

Ticker impact

$NWPXBullishMedium confidence
Context

Northwest Pipe reported Q2 CY2026 revenue of $159.5M (+19.7% YoY) and GAAP EPS of $1.62, both above consensus.

Expected impact

Likely supports upside bias versus pre-report expectations, though the guided full-year EPS decline may cap follow-through.

Evidence & confidence

The article provides concrete Q2 results (revenue, EPS, margin) and a specific next-12-month full-year EPS expectation ($4.99 to $4.90, -1.8%).

Market effects

Improved margins and EPS growth in water infrastructure manufacturing may reinforce demand read-through for integrated pipeline-related capex.

Texas integrated pipeline project context could support regional infrastructure spending sentiment.

Limited direct global linkage beyond broader industrial infrastructure demand.

Counterpoint

Despite the Q2 beat, the article cites expected full-year EPS decline (-1.8%) and revenue growth deceleration, which could reduce the durability of the rally.

Key entities

  • Northwest Pipe

    Reported Q2 CY2026 revenue $159.5M (+19.7% YoY) and GAAP EPS $1.62, with operating margin 13.3%.

Related articles

$NWPXMed

NWPX Infrastructure, Inc. (NWPX): Results of Operations and Financial Condition

NWPX Infrastructure, Inc. (NWPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_954632.htm EXHIBIT 99.1 ex_954632.htm Exhibit 99.1 NWPX Infrastructure Announces Second Quarter 2026 Financial Results • Record net sales of $159.5 million, up 19.7% year-over-year, and record gross profit of $34.4 million, up 35.5% year-over-year • Record Water Tran

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.

$KRMNMed

Karman Q2 Earnings Call Highlights

Karman (NYSE:KRMN) reaffirmed full-year organic growth of 25% or more after Q2 organic revenue rose 24.4% YoY. Management expects second-half revenue to rise sequentially, with Tactical Missiles and IDS, Hypersonics, and Space and Launch as key drivers. Karman converted one contingent supply agreement into a firm contract and plans capacity expansion, plus a £70m ($94m) Walker Precision acquisition.